Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dana Albon

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Annals of the American Thoracic Society|March 16, 2026
Renal Function Decline in Adults with Cystic Fibrosis Experiencing Pulmonary ExacerbationsDana Albon
Pediatric Pulmonology|April 12, 2024
Clinical effectiveness of elexacaftor/tezacaftor/ivacaftor in a man with A559T and 3120+1G>CFTR variantsEmily Mitchell, Dana Albon
Chest|May 12, 2020
Potential Implications of the COVID-19 Pandemic on the Homeless PopulationDana Albon, Morgan Soper, Anthony Haro
Therapeutic Advances in Respiratory Disease|November 15, 2024
Modulator-refractory cystic fibrosis: Defining the scope and challenges of an emerging at-risk populationLindsay Somerville, Larry Borish, Imre Noth, et al.
Therapeutic Advances in Respiratory Disease|December 23, 2022
Impact of elexacaftor/tezacaftor/ivacaftor on depression and anxiety in cystic fibrosisLijia Zhang, Dana Albon, Marieke Jones, et al.
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|January 30, 2020
Prevalence and Risk Factors for Iron Deficiency in Adults With Cystic FibrosisLucy S Gettle, Adrienne Harden, Meagan Bridges, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|January 11, 2020
Use of mepolizumab in adult patients with cystic fibrosis and an eosinophilic phenotype: case seriesLijia Zhang, Larry Borish, Anna Smith, et al.
Pediatric Pulmonology|November 28, 2024
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Hemoglobin Levels and Mean Corpuscular Volume in Adults With Cystic FibrosisAmber James, Z Galvin Li, Magdalene Kwarteng, et al.
Respiratory Medicine Case Reports|May 17, 2017
A case of massive hemoptysis following transesophageal echocardiogramSean J Callahan, Robert M Jones, Dana Albon, et al.
Journal of Cosmetic Dermatology|November 17, 2025
Cutaneous Adverse Effects of Elexacaftor-Tezacaftor-Ivacaftor: A Single Center Cohort Study on Acne Severity in Adults With Cystic FibrosisAaron D Smith, Catherine E Lyons, Lindsay Somerville, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Annals of the American Thoracic Society|March 16, 2026
Renal Function Decline in Adults with Cystic Fibrosis Experiencing Pulmonary ExacerbationsDana Albon
Pediatric Pulmonology|April 12, 2024
Clinical effectiveness of elexacaftor/tezacaftor/ivacaftor in a man with A559T and 3120+1G>CFTR variantsEmily Mitchell, Dana Albon
Chest|May 12, 2020
Potential Implications of the COVID-19 Pandemic on the Homeless PopulationDana Albon, Morgan Soper, Anthony Haro
Therapeutic Advances in Respiratory Disease|November 15, 2024
Modulator-refractory cystic fibrosis: Defining the scope and challenges of an emerging at-risk populationLindsay Somerville, Larry Borish, Imre Noth, et al.
Therapeutic Advances in Respiratory Disease|December 23, 2022
Impact of elexacaftor/tezacaftor/ivacaftor on depression and anxiety in cystic fibrosisLijia Zhang, Dana Albon, Marieke Jones, et al.
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|January 30, 2020
Prevalence and Risk Factors for Iron Deficiency in Adults With Cystic FibrosisLucy S Gettle, Adrienne Harden, Meagan Bridges, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|January 11, 2020
Use of mepolizumab in adult patients with cystic fibrosis and an eosinophilic phenotype: case seriesLijia Zhang, Larry Borish, Anna Smith, et al.
Pediatric Pulmonology|November 28, 2024
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Hemoglobin Levels and Mean Corpuscular Volume in Adults With Cystic FibrosisAmber James, Z Galvin Li, Magdalene Kwarteng, et al.
Respiratory Medicine Case Reports|May 17, 2017
A case of massive hemoptysis following transesophageal echocardiogramSean J Callahan, Robert M Jones, Dana Albon, et al.
Journal of Cosmetic Dermatology|November 17, 2025
Cutaneous Adverse Effects of Elexacaftor-Tezacaftor-Ivacaftor: A Single Center Cohort Study on Acne Severity in Adults With Cystic FibrosisAaron D Smith, Catherine E Lyons, Lindsay Somerville, et al.
Pageof 4